We’re the Strategic Meeting Point for the Next Wave of MASH Drug Development
The 10th MASH Drug Development Summit is purpose-built for biotech and pharma leaders advancing the next generation of MASH therapies.
A Curated Environment
Unlike broader liver congresses that focus primarily on clinical data presentation, this industry-led summit provides a highly curated environment dedicated to solving the strategic, scientific, and operational challenges of MASH drug development. Attendees benefit from in-depth discussions, meaningful networking opportunities, and practical insights that accelerate therapeutic progress.
A Senior Audience
Featuring 22+ expert speakers from organizations including Novo Nordisk, Pfizer, Madrigal Pharmaceuticals, Insitro, and Takeda, the summit attracts a highly senior audience of decision-makers. Last year's biopharma audience included 27% C-suite executives, 11% Vice Presidents, and 20% Heads, Directors, and Managers, ensuring access to the individuals shaping development strategy and partnership decisions.
More Opportunities for Partners
To maintain a highly scientific, industry-focused environment, we carefully limit the number of service provider partners involved. This creates a stronger ratio, more valuable interactions, and a greater opportunity for sponsors to stand out, build relationships, and position themselves as partners of choice within the MASH ecosystem.
Explore the Agenda
Reflect on the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Industry Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.